For the past week, a pharmaceutical company called Mylan has been making headlines as the latest example of corporate greed gone amok. It’s a similar story to that of Martin Shkreli, who hiked the price of the AIDS drug Daraprim 5,556 percent, from $13.5 to $750 per tablet. In the case of Mylan, they’ve been under fire for raising the price of the EpiPen, on which they have a monopoly, 400% over a relatively short period of time. Since acquiring the drug from Merck in 2008, Mylan has increased its price from $100 to as much as $600.
We’ve learned that the company responsible for the increase, Mylan Pharmaceuticals, is a Clinton Foundation donor helmed by the daughter of a Democratic Senator.
The CEO of Mylan is Heather Bresch, daughter of West Virginia Senator Joe Manchin. Mylan CEO Bresch reportedly earned a salary of close to $19 million in 2015, an increase in 671% over the same period in which the EpiPen rose in price.
Hillary's SHADY EpiPen ties... - Allen B. West - AllenBWest.com (external - login to view)
“[I]t’s just the latest troubling example of a company taking advantage of its consumers,” she said in a statement. “It’s wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them....
...Clinton went on to reiterate her position that drug price hikes should be linked with better patient outcomes and demonstrated improvements in value, and demanded that Mylan “immediately reduce the price of EpiPens.” ”
fortune.com/2016/08/24/clinto...-mylan-epipen/ (external - login to view)